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Lemierre's syndrome is a septic thrombophlebitis of the internal jugular vein, which can lead to severe
systemic illness. We report a case of an otherwise healthy 26-year-old man who suffered from phar-
yngitis followed by septic shock requiring intubation and vasopressor support from Fusobacterium
necrophorum bacteremia. The septic emboli to his lungs caused complicated bilateral parapneumonic
effusions, which recurred after initial drainage. He required bilateral chest tubes and intrapleural tPA to
successfully drain his effusions. His fever curve and overall condition improved with the resolution of his
effusions and after a 33-day hospitalization, he recovered without signiﬁcant disability. The severity of
his illness and difﬁcult to manage complicated parapneumonic effusions were the unique facets of this
case. Using an evidence-based approach of tPA and DNase for complicated parapneumonic effusions in
Lemierre's syndrome can be safe and effective.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lemierre's syndrome describes a septic thrombophlebitis of the
internal jugular vein in the setting of an oropharyngeal infection [1].
This syndrome was originally described by Andre Lemierre as
“anaerobic postanginal septicaemias” occurring in young healthy
adults [2] and has been increasingly reported in the medical litera-
ture over this past decade [3]. The thrombophlebitis of the internal
jugular vein can spread septic emboli to the lung, liver, bones, joints
and soft tissueswith resultant fever and complications speciﬁc to the
organs involved [4]. The inclusion of positive blood cultures or ul-
trasonographicevidenceof clot aspartof thedeﬁnitionvaries [1]. The
organism commonly associated with Lemierre's syndrome is Fuso-
bacterium necroforum, an anaerobic gram-negative bacterium
commonly isolated in the oropharynxandupper respiratory tract [5].
The authors present a case of Lemierre's syndrome with special
attention to the management of recurrent complicated para-
pneumonic effusions.ergency Department; MIST,
lasminogen activator; VATS,
e Medicine Fellow, University
ox 692, Rochester, NY 14642-
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Ltd. This is an open access article u2. Case report
Our patient is a previously healthy 26-year-old male with a
history of tobacco dependence who presented to a local Emergency
Department (ED) with fevers, chills, myalgias and sore throat. He
was discharged with a presumed viral URI in the setting of a
negative rapid strep test. Two weeks later he presented to the ED
with a dry cough, pleuritic chest pain and non-speciﬁc upper
abdominal pain. He had decreased breath sounds and dullness to
percussion in bilateral lung bases with no abnormalities on cardiac
exam. His peripheral oxygen saturation on room air was above 90%
and blood work revealed leukocytosis (12.6  103/mL with 7%
bands), a hematocrit of 43.9%, and severe thrombocytopenia
(platelet count of 7000  1000/mL). Also notable were renal insuf-
ﬁciency with a BUN 55 mg/dl and Cr 1.8 mg/dl, a venous lactate of
4.3 mmol/l and an arterial blood gas on room air of pH 7.45, PCO2
33.9 mmHg and PO2 62.3 mmHg. His chest CT showed bilateral
pleural effusions and scattered septic emboli (Fig. 1).
He rapidly developed septic shock requiring vasopressors and
intubation. He was transferred to our institution, initially for
consideration for plasmapheresis due to concern for idiopathic
thrombocytopenic purpura. However, on arrival, Lemierre's syn-
drome was suspected, prompting empiric treatment with Metro-
nidazole and Ampicillin-sulbactam without anticoagulation due to
thrombocytopenia. Blood cultures from the transferring hospital
later grew F. necroforum. A CT scan of his neck revealed amild ﬁllingnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A. Axial view of a chest CT on admission showing a cavitary lesion in the left upper lobe (thick red arrow) and bilateral pleural effusions (thin blue arrows). B. Coronal view of
a chest CT showing similar ﬁndings as the axial images of a cavitary left upper lobe lesion (thick red arrow) with focus on right sided consolidation (double thin blue arrows) and
smaller left sided effusion (Single thin blue arrow). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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clearance, he had ongoing fevers and leukocytosis in the setting of
recurrent bilateral complicated parapneumonic effusions (pH of 7.0
and LDH of over 5000U/L bilaterally), prompting placement of
bilateral chest tubes. In consultation with the thoracic surgery
service, intra-thoracic tissue plasminogen activator (tPA) was
administered (alteplase 12.5 mg twice daily) for 3 days to suc-
cessfully drain each effusion (Fig. 2). Video-assisted thoracoscopic
surgery (VATS) was not required. After seventeen days, he was
extubated, his fevers abated and platelet count slowly recovered.
After a 33-day hospitalization, he was discharged on a course of
Amoxicillin-clavulanate for a total course of 5 weeks after deﬁnitive
drainage with outpatient follow up in another state.
3. Discussion
This case was unique due to the severity of his illness and the
use of tPA for bilateral complicated parapneumonic effusions. He
required vasopressors for septic shock in addition to intubation for
acute respiratory distress syndrome (under 10% of cases reported)
[1]. The presence of pleural involvement with septic emboli is
common with an incidence up to 92%, with empyemas present in
17e27% of Lemierre's syndrome cases [1,5].
Multiple studies in adults described chest tube placement forFig. 2. A. Axial view of a chest CT after removal of chest tubes with evidence of resolving ple
Coronal view of a chest CT following chest tube removal showing improvement in bilateral e
legend, the reader is referred to the web version of this article.)Lemierre's (with culture positive Fusobacterium necrophorum)
without tPA administration or VATS [6,7]. Only one study noted use
of tPA (streptokinase) with success in avoiding surgery in a
complicated parapneumonic effusion [8]. If an empyema is present
in Lemierre's syndrome, minimally invasive VATS [9] or even tho-
racotomy with decortication [10,11] can be required.
Management of complicated parapneumonic effusions is an
area of active discussion in the medical literature. The ability of
intra-pleural tPA to break down septations and deoxyribonuclease
(DNase) to decrease the ﬂuid viscosity is established [12]. However,
guidelines addressing tPA-DNase use are debated with proponents
of this practice citing improved drainage of the effusions in the
MIST II trial [13] and others contending that VATS is an effective
option for management of empyema and should supercede
drainage with chest tubes or intrapleural ﬁbrinolytics [14].
4. Conclusion
The use of tPA-DNase can be an effective and safe treatment
strategy for the complicated parapneumonic effusions in patients
with Lemierre's syndrome. Given the severity of illness possible
from pulmonary involvement in Lemierre's syndrome, the authors
propose that chest tubes and ﬁbrinolytics should be considered
when complicated parapneumonic effusions arise.ural effusions and improving areas of cavitation prior to discharge (thick red arrow). B.
ffusions and septic emboli. (For interpretation of the references to colour in this ﬁgure
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